Lyme disease, caused by the bacterium Borrelia burgdorferi sensu lato, is the most common zoonosis in North America and is a problem in many parts of the world (31, 32) . The disease is transmitted by hard-body ticks of the genus Ixodes, which usually acquire the infection from small rodents such as the white footed mouse (Peromyscus leucopus). Infected ticks subsequently transmit the spirochete to naïve mice, larger mammals such as deer, or to an inadvertent human host. Environmental factors such as climate change (24, 25), reforestation and increasing deer populations (30) are probably responsible for an increasing range of infected ticks and Lyme disease. Since the OspA (outer surface protein A)-based Lyme disease vaccine (33) was discontinued for use in humans, prevention of the spread of Lyme disease has relied solely on personal protection from ticks, prophylactic antibiotic treatment, and tick control (28) .
B. burgdorferi has a unique genome composed of a linear chromosome and more than 20 extrachromosomal elements or plasmids, most of which are linear (9, 15)..Each of the linear plasmids is terminated by covalently closed hairpin ends or telomeres (3, 8, 16, 35) . Replication of the linear plasmids initiates at a central origin of replication and proceeds bidirectionally (4, 27) . The resulting dimer junctions are recognized and processed by ResT, a telomere resolvase, which catalyzes a two-step transesterification reaction known as telomere resolution (10, 11, 20) .
This reaction generates the covalently closed hairpin telomeres found on the ends of all linear replicons in Borrelia species (see (10) for a recent review).
The B. burgdorferi telomere resolvase has been studied extensively (2, 12, (18) (19) (20) (34) (35) (36) (37) and the reaction is catalyzed through a nucleophilic attack by tyrosine 335, which forms a 3'phosphotyrosyl-enzyme intermediate. Subsequently, a conformational change occurs in order to position the 5'-OH terminus of the opposite DNA strand for nucleophilic attack of the protein- those of some other DNA breakage and reunion enzymes, specifically type IB toposiomerases and tyrosine recombinases, and it possesses a hairpin binding module that may be similar to that found in cut-and-paste transposases (1) .
As ResT is essential for the survival of B. burgdorferi (7, 34), and a telomere resolvase has only been reported in one other bacterium, it is a promising target for the development of highly specific anti-borrelial agents for the prevention and treatment of Lyme disease. Drugs that target ResT will be useful for mechanistic studies on the enzyme and may provide more specific and safer treatment alternatives than antimicrobial therapy with currently available drugs (17) , which can result in the spread of antibiotic resistance. ResT-specific drugs might also be useful on an environmental scale to eradicate B. burgdorferi from mammalian reservoirs such as the white-footed mouse, thus preventing environmental spread of infected ticks and reducing transmission to humans (13, 38).
In this study we report the development of a high-throughput screening assay to identify
ResT inhibitors. The fluorescence-based assay was used to screen a library of 27, 520 small molecules. We report the finding of six inhibitors of ResT with IC 50 values between 2 and 10 µM.
Materials and Methods

Chemicals and Reagents
All chemicals used were of analytical grade and did not require further purification. (Calgary, Alberta). Synthesis and use of oligonucleotides containing a 5' bridging phosphorothiolate has been previously described (6, 12, 18) .
Protein and Plasmid DNA Purification
A bacterial strain (GCE203) carrying the plasmid pYT1 (36) was grown overnight at 30°C with agitation at 250 rpm in a Fernbach flask containing 1 L of Luria-Bertani (LB) broth and 50 µg/ml kanamycin. The plasmid pYT1 was purified using a Qiafilter Plasmid Mega Kit (Qiagen) according to the instructions for low copy DNA. The DNA concentration was determined via absorbance at 260 nm. For use in telomere resolution assays, plasmid DNA was digested using PstI (New England Biolabs) according to manufacturer's specifications.
To overexpress wild-type ResT, a 5 ml starter culture of GCB195 (20) was grown overnight at 30°C in LB broth containing 1% glucose, 30 µg/ml chloramphenicol, and 100 µg/ml ampicillin. It was then added to 1 L of LB broth containing 1% glucose, 30 µg/ml chloramphenicol, and 100 µg/ml ampicillin and grown to an OD of 0.4 at 32°C. Protein expression in E. coli was induced by the addition of IPTG to 1 mM, and growth continued at 18°C and 250 rpm overnight. Recombinant ResT 1-449 was purified as previously described (20) .
To express ResT 164-449 a 5 ml culture pYT42 was grown overnight at 37°C and 250 rpm in LB broth containing 100 µg/ml carbenicillin and 25 µg/ml of chloramphenicol. One ml of this starter culture was used to inoculate 250ml of LB containing 100 µg/ml carbenicillin and 25 µg/ml of chloramphenicol. This culture was incubated at 37°C and 250 rpm to an OD of 0.45.
IPTG was added to 0.75 mM, and the culture was incubated at 18°C and 250 rpm overnight.
ResT 164-449 was purified as previously described (37). ResT activity was measured by a fluorescence-based high throughput screen depicted in Fig. 1 . The reactions were performed and measured in 384-well black microplates (catalogue number 781076, Greiner Bio-one). The final assay conditions were: 10% DMSO (dehydrated with molecular sieves, pore size 3Å ,Fisher Scientific), 395 pM PstI-linearized pYT1, 25mM
Tris-HCl (pH 8.5), 1mM EDTA, 100mM NaCl, 19µg/ml bovine serum albumin (BSA) and 11nM ResT in a final reaction volume of 30 µl. Reactions were assembled by the MultiProbe HT EX Liquid Handling System by the ordered addition of 3 µl of DMSO, 21 µl of reaction mix containing the DNA, Tris buffer, EDTA, NaCl and BSA, and 6 µl of ResT. Following a 15 minute incubation at room temperature, 6 µl Na 3 PO 4 was added to the reaction mixture to 42 mM and the reactions incubated for 10 minutes at room temperature. Subsequently, an equal volume (36 µl) of SYBR Green (Molecular Probes) at a 2X concentration in 10 mM Tris-HCl (pH 7.5) + 1 mM EDTA was added. The final reaction volume was 72 µl. The plates were read on a Fusion Universal Microplate Analyzer (PerkinElmer) at an excitation wavelength of 485nm and an emission wavelength of 530nm. The ResT stock was kept on ice between additions.
Primary Screening
ResT was screened against a Canadian Chemical Biology Network Library of 27,520 compounds in a semi-automated fashion on an eight pin MultiProbe HT EX Liquid Handling System. Reactions contained 10µM concentrations of the library compounds. Due to mechanical constraints, 96 reactions were performed at a time in 384-well plates (4 groups of reactions per 384-well plate). Each group of 96 reactions included eight positive controls (+ResT) and eight negative controls (-ResT). For the negative controls, buffer was added instead of ResT. Primary control is the mean of the positive control data, and mean neg. control is the mean of the negative control data.
Secondary Screening
The inhibitors identified from the primary screen were confirmed by repeating the assay on the compounds identified from the primary screen. Compounds that retained the ability to inhibit ResT activity by 70% or more were classified as confirmed inhibitors. These compounds were also tested in the presence of 0.01% (w/v) BSA, and 1 mM DTT, each in separate trials.
The compounds were also tested for their ability to quench fluorescence by incubating the compounds with completed ResT reactions, followed by addition of Na 3 PO 4 and SYBR Green as noted above. Assembled oligonucleotides were electrophoresed on 4% Metaphor gel for 3.5 hours at 30 mA to separate the annealed substrate from unannealed oligonucleotides and unincorporated [ -32 P]ATP. Gels were stained using ethidium bromide and bands corresponding to the assembled substrate were excised. DNA was extracted from the gel slices by freezing the gel slice at -80°C for 20 minutes and then spinning through a Spin-X ® Centrifuge tube filter (0.22 µm cellulose acetate in a 2.0 mL tube, Costar) for 8 minutes at 8000 rpm and 4°C. The OPS substrates were made from oligos OGCB116 -5'-GAT CCA CTC TAT ACT AAT AAA AAA TTA TAT AT-3', and OGCB117 -5' ATA ATT TTT TAT TAG TAT AGA GTG-3', and were assembled using as previously described (1, 12, 18, 19) . OGCB116 was 5' end-labeled as described above with [ -32 P]ATP, and OGCB117 was similarly phosphorylated, but with cold ATP. In both reactions, the polynucleotide kinase was heat-inactivated at 65°C for 45 minutes. The oligos were annealed as described above and then ligated at 16°C for 2 hours. The replicated telomeres were purified as described above. The 140mer wild type replicated telomere was composed of annealed oligonucleotides OGCB2 -5'-GAT CCA AGT TAA AGT TAG CAA TTT AAA GGG (pH 8.5), 100 mM NaCl, 1 mM EDTA, and 25% glycerol. All reactions were incubated at 30°C
for 30 minutes and were stopped using 0.1% SDS. Samples were loaded onto a 5%
polyacylamide SDS gels and run in 1X E buffer (11) 
Results and Discussion
Development of a high-throughput screen to identify inhibitors of ResT
A schematic describing the fluorescence-based high-throughput screen developed for
ResT, based upon its unique activity, is shown in In order to determine the reliability of the screening assay, replicates of positive and negative controls (+ResT and -ResT, respectively) were manually prepared. The Z'-factor, a parameter calculated using control data, is indicative of the assay quality (39) and was found to be 0.84 for the manual assay (data not shown). A Z'-factor of 0.5 or greater is indicative of an excellent screen with a robust signal window (39). Following optimization of the manually prepared reaction conditions, an eight-pin MultiProbe HT EX Liquid Handling System (LHS) (Perkin Elmer) was programmed to run the assay semi-automatically in a 384-well plate setting.
One hundred ninety-two replicates of both positive and negative control assays were prepared using the MultiProbe LHS, yielding a Z'-factor of 0.54 (data not shown).
Screening process for a chemical library of 27,520 compounds
The compound library that was used to screen for ResT inhibitors was obtained from the Canadian Chemical Biology Network (http://www.ccbn-rcbc.ca/?q=profile) and contained 27,520 synthetic and natural small molecules (http://www.ccbn-rcbc.ca/?q=canadiancollection).
A schematic of the screening method is summarized in Fig. 2 . The primary and secondary screens were run in a semi-automated fashion as described in Experimental Procedures. The Z'- compounds were tested for their ability to inhibit ResT-mediated telomere resolution using an in vitro gel-based assay (Fig. 3A) . Compounds were screened at a concentration of 10 µM using standard ResT reaction conditions previously used for mechanistic studies of the enzyme (1, 2, 12, 18-20, 36, 37). Compounds that did not inhibit ResT activity at a level of 70% or more under standard assay conditions were also eliminated.
The 16 remaining compounds were tested for the ability to bind to double-stranded DNA, a feature that would likely result in the ability to inhibit a large number of DNA metabolizing Finally, the 16 remaining compounds were reordered from their respective suppliers and the IC 50 for each was determined using the gel-based telomere resolution assay (Fig. 3A) . substitution at the scissile phosphate (6, 12, 18) . In an OPS substrate, the 5'-bridging oxygen, which is responsible for the nucleophilic attack of the phosphotyrosine linkage in the second transesterification is replaced with sulfur (Fig. 5A ). Sulfur is a good leaving group, resulting in efficient substrate cleavage, but a poor nucleophile in phosphate chemistry; thus, the phosphotyrosine linkage between ResT and the DNA substrate cannot be transesterified, leaving
ResT permanently attached to the substrate.
ResT reactions with the various inhibitory compounds were performed using an OPS oligonucleotide substrate and the cleavage step was monitored by assessing the amount of CPD generated, using a denaturing (SDS) gel assay (Fig. 5A) . The level of DNA cleavage in the presence (10 µM) of each inhibitor relative to the absence of inhibitor is shown in Fig. 5B To compare the effect that each inhibitor had on the DNA cleavage step relative to the second transesterification step (hairpin formation), the effect of each compound on the full telomere resolution reaction using an unmodified oligonucleotide substrate was determined. All of the molecules demonstrated 70% or more inhibition of telomere resolution by ResT on the oligonucleotide substrates (Fig. 5C ), and all were significantly different (>95%) from the positive control (+ResT) using a two-tailed Student's t-test. For all of the compounds, although cleavage was affected to varying extents, the effect on the final product forming step of the reaction was more pronounced. Since the ligation step was assessed indirectly here, we do not know whether the greater effect of the inhibitors on this step stems from a direct inhibition of the reaction chemistry or from some other mechanism, such as inhibition of a conformational change required for the second chemical step. Similarly, a defect at the cleavage step might have resulted from a direct effect upon the reaction chemistry or from perturbation of a previous step, such as DNA binding and/or subsequent dimerization by ResT.
Ability of ResT to bind DNA in the presence of inhibitors
DNA binding by ResT is an important feature of the telomere resolution reaction. The region of the protein that recognizes and binds to a specific sequence in the replicated telomere substrate (TAGTA or box 3) resides in the C-terminal catalytic domain, ResT 164-449 (36, 37).
Specific binding can be assessed using an electrophoretic mobility shift assay with purified The inhibition of telomere resolution exhibited by five of the six inhibitory compounds may be due to the ability of the compounds to interfere with specific binding to the telomere substrate by the C-terminal region of the protein. However, it is important to note that the DNA binding assays were performed using the C-terminal domain ResT 164-449 , because the full-length protein is subject to aggregation and cannot be used in sequence-specific DNA binding assays. and the other inhibitory compounds, as discussed below.
Classification of inhibitors of ResT
A comparison of the effect of the six inhibitors on telomere cleavage, resolution and sequence-specific DNA binding (Fig. 6) showed both similarities and differences. In all cases a more profound effect upon telomere resolution relative to cleavage was observed. This was not surprising since the same active site promotes both chemical steps. Therefore, a compound that either binds directly to the active site or that affects other steps in the reaction would be expected Class one contains compounds 8 and 14 (Fig. 6, upper left panel) . The level of sequencespecific DNA binding by ResT in the presence of both of these compounds roughly correlates with the level of telomere cleavage. This suggests that the level of inhibition in terms of telomere cleavage may be due to the inability of ResT to bind DNA.
Class two comprises compound 11 (Fig. 6 , upper right panel), which exhibited near contol levels of telomere cleavage and greater than control levels of ResT 164-449 DNA binding.
Compound 11 may be targeting any number of steps after, but not before telomere cleavage.
Finally, compounds 5, 15 and 22 were assigned to Class three (Fig. 6, bottom The most likely explanation for the lack of efficacy in the whole cell assay that our inhibitors are not effectively taken up by B. burgdorferi, or that they are actively exported from the cell.
Options for further development of anti-borrelial ResT inhibitors include further analysis and modification of the six inhibitory compounds through medicinal chemistry approaches, or the screening of substantially larger small molecule libraries. In view of the structural heterogeneity of the six compounds and their chemical characteristics the latter approach would appear to hold the greatest promise. In summary, the high-throughput screening assay developed in this paper provides a starting point in the quest for future development of novel anti-borrelial drugs as well as small molecule inhibitors that will be helpful for further dissection of the reaction mechansim. This dye binds specifically to double-stranded DNA producing a fluorescent signal in the presence of product, but not unreacted substrate. B) Positive (red) and negative (blue) control data for the screening of a library of 27,520 compounds using the assay in 384 well plates.
Positive samples were treated with ResT, whereas negative samples were untreated. 
